Apellis Pharmaceuticals has identified internal structural variations in the 19-gauge filter needle included in certain Syfovre injection kits as part of its investigation into the recent reports of retinal vasculitis.
The company is now exclusively distributing injection kits with the 18-gauge filter needle, according to a press release.
In addition, Apellis recommended that ophthalmologists “immediately discontinue use of any injection kits that contain the 19-gauge filter needle and use injection kits with the 18-gauge filter needle, which are already in distribution.”
“This